{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:37:39Z","timestamp":1761568659645,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.clgc.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T22:47:28Z","timestamp":1464302848000},"page":"e545-e548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Patient With Pancytopenia, Intractable Epistaxis, and Metastatic Prostate Cancer: How Correct Diagnosis of Primary Hyperfibrinolysis Helps to Stop the Bleeding"],"prefix":"10.1016","volume":"14","author":[{"given":"Mohammad A.S.","family":"Jafri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine V.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Much","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Petrylak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai A.","family":"Podoltsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.05.002_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2016.05.002_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1464-410X.2005.05798.x","article-title":"A\u00a0retrospective study of the time to clinical endpoints for advanced prostate cancer","volume":"96","author":"Sharifi","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1097-0142(19920801)70:3<656::AID-CNCR2820700319>3.0.CO;2-T","article-title":"Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid","volume":"70","author":"Cooper","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2016.05.002_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clgc.2016.05.002_bib5","first-page":"5340","article-title":"Amplification of urokinase gene in prostate cancer","volume":"61","author":"Helenius","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2016.05.002_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1006115218786","article-title":"The urokinase plasminogen activator system as a target for prognostic studies in breast cancer","volume":"52","author":"Stephens","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clgc.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","article-title":"Prevention and treatment of major blood loss","volume":"356","author":"Mannucci","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003495-198529030-00003","article-title":"Clinical application of inhibitors of fibrinolysis","volume":"29","author":"Verstraete","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.clgc.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJM196905152802011","article-title":"Epsilon aminocaproic acid\u2013a dangerous weapon","volume":"280","author":"Ratnoff","year":"1969","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2016.05.002_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2141.2000.02270-8.x","article-title":"All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia","volume":"110","author":"Brown","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clgc.2016.05.002_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/07357900009031823","article-title":"Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel","volume":"18","author":"Sallah","year":"2000","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clgc.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1200\/JCO.2009.25.2502","article-title":"Systemic fibrinolysis caused by tissue plasminogen activator-producing metastatic breast cancer","volume":"28","author":"Naina","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.05.002_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0049-3848(92)90047-E","article-title":"Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer","volume":"66","author":"Okajima","year":"1992","journal-title":"Thromb Res"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316301288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316301288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:25:07Z","timestamp":1761564307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767316301288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1558767316301288"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.05.002","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Patient With Pancytopenia, Intractable Epistaxis, and Metastatic Prostate Cancer: How Correct Diagnosis of Primary Hyperfibrinolysis Helps to Stop the Bleeding","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}